<p>The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof; wherein R1-R7, X, Y, m, and n are as described herein. Compounds of the present invention are useful for the treatment of a variety of diseases associated with overexpression of the CCR2 receptor.</p>
申请公布号
WO2010080873(A1)
申请公布日期
2010.07.15
申请号
WO2010US20315
申请日期
2010.01.07
申请人
GLAXO GROUP LIMITED;HONG, XUAN;HUGHES, TERRY, VINCENT;MILLER, NATHAN, A.;MISKOWSKI, TAMARA, ANN;SEHON, CLARK, A.
发明人
HONG, XUAN;HUGHES, TERRY, VINCENT;MILLER, NATHAN, A.;MISKOWSKI, TAMARA, ANN;SEHON, CLARK, A.
